ClinicalTrials.Veeva

Menu

A Smart Sleep Apnea Self-management Support Programme(4S) for Subjects With Sleep Apnea

The University of Hong Kong (HKU) logo

The University of Hong Kong (HKU)

Status

Not yet enrolling

Conditions

Obstructive Sleep Apnea

Treatments

Behavioral: General Hygiene Information (GH)
Behavioral: Smart Sleep Apnea Self-management Support Programme (4S)

Study type

Interventional

Funder types

Other

Identifiers

NCT05390138
UW 21-135

Details and patient eligibility

About

OSA is a chronic disease with high prevalence that parallels with increasing obesity. Self-management programmes are perceived to be cost-effective in long-term OSA patient care and can supplement regular medical treatments. The current study attempt to examine the effectiveness of 4S on improving apnea severity, cardiovascular health and quality of life in 4S intervention (4S) group, compared to the general hygiene (GH) control group.

Full description

OSA is a chronic disease with high prevalence that parallels with increasing obesity. OSA affects around 12% and 24% of adults in Hong Kong and China Mainland, respectively. Chronic intermittent hypoxia and sleep fragmentation of OSA leads to cardiometabolic and neurocognitive sequelae (e.g. hypertension, diabetes, daytime sleepiness and depression). Long-term, multidisciplinary management involving patients in decision-making of treatment strategies, shifting from positive airway pressure (PAP) device-focused to the patient-centered chronic care model has been suggested.

Mobile instant messaging (such as WhatsApp/WeChat) are popular and inexpensive for interactive messaging. Smartphone-based self-management interventions were reported improved self-efficacy and clinical outcomes in patients with chronic diseases. The investigator only found one mobile health application to support CPAP therapy for OSA and one ongoing trial of OSA self-management telematic support to improve CPAP adherence. There is underutilization of mobile technology in patient-centered self-management programmes to improve PAP treatment and lifestyle modifications in OSA.

The current study attempt to examine the effectiveness of 4S on improving apnea severity, cardiovascular health and quality of life in 4S intervention (4S) group, compared to the general hygiene (GH) control group. Questionnaire and simple fitness assessment will be used to assess the effectivness of the intervention at 4-month and 12-month follow-up. Focus group interview will be conducted to collect qualiatative feedback on the intervention.

Enrollment

120 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • aged 18 years and above;
  • diagnosis of moderate to severe obstructive sleep apnea (AHI≥15);
  • physically inactive (self-reported moderate physical activity per week of <150 minutes);
  • overweight (BMI≥23 kg/m2);
  • mentally, cognitively and physically fit to join the trial as determined by the doctor in-charge and responsible clinical investigators;
  • able to speak and read Chinese;
  • willing to complete the questionnaires and assessments;
  • has a smartphone with instant messaging function (eg. WhatsApp/WeChat); and
  • willing to give informed consent.

Exclusion criteria

  • sleep disorder other than OSA;
  • clinically significant psychiatric, neurological, or medical disorder other than OSA; and
  • use of prescription drugs or clinically significant drugs affecting sleep.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

120 participants in 2 patient groups, including a placebo group

Smart Sleep Apnea Self-management Support Programme (4S)
Experimental group
Description:
Patients will receive Smart Sleep Apnea Self-management Support Programme (4S) in addition to usual care
Treatment:
Behavioral: Smart Sleep Apnea Self-management Support Programme (4S)
General Hygiene Information (GH)
Placebo Comparator group
Description:
Patients will receive general hygiene information (GH) in addition to usual care
Treatment:
Behavioral: General Hygiene Information (GH)

Trial contacts and locations

0

Loading...

Central trial contact

George Cheung, MPhil; Agnes YK Lai, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems